Evidence and Guidance of Hepatitis C Therapy in Pregnancy – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“Hepatitis C remains a massive public health problem, but promise has arrived in direct-acting antivirals (DAAs).
In this review, the authors review the state of the evidence regarding hepatitis C therapy in pregnancy, arriving at a conclusion that while larger prospective trials are being conducted, shared-decision making for HepC therapy in pregnancy should be considered given the potential for pregnancy as a major window to combatting this infection. They also provide guidance on counseling about therapy, open registries, and ongoing trials.”
Title: Hepatitis C Treatment During Pregnancy: Time for a Practice Change
Authors: Karley Dutra, Jonathan M. Fenkel
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 14, 2026, 12:02ANA Testing as Routine Diagnostic Work-Up of Women Experiencing REPL – RBMO
-
Apr 13, 2026, 08:40Antonio La Marca: April 15 Webinar to Focus on Thermal Ablation for Fibroids and Adenomyosis
-
Apr 13, 2026, 08:34Raising Awareness of Endometriosis at Paris Women’s Health Forum 2026 – Filière Endométriose Île-de-France
-
Apr 12, 2026, 07:31Antonio La Marca: Upcoming Webinar to Explore Uterine Artery Embolization and Thermal Ablation of Fibroids
-
Apr 12, 2026, 07:28South Carolina, IVF is Under Threat Again! – RESOLVE
-
Apr 12, 2026, 07:18New Series Explores Paths Into Reproductive Medicine Leadership – ASRM
-
Apr 12, 2026, 07:11Latest Episode of RCOG Surgical Skills Project – RCOG
-
Apr 12, 2026, 07:03Christopher Robinson: Uterine Artery Injury During Cesarean Deliveries
-
Apr 12, 2026, 06:58Robert Brown: Overview of Maternal Mortality